Health & Personal Care
HIGH
FDA DRUG
Glenmark Pharmaceuticals Recalls Ondansetron Tablets Over Packaging Issues
Glenmark Pharmaceuticals recalled nearly 97,000 packs of Ondansetron Orally Disintegrating Tablets on December 30, 2025. Defective blister packs may not fully seal, leading to tablets falling out. Consumers should stop using the product immediately and contact healthcare providers.
ONDANSETRON
Defective container: